BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer

CAMBRIDGE, Mass., Nov. 26, 2018 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced ... Regenerative Medicine, Personnel BlueRock Therapeutics, stem cell, Cell+Gene
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news